Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40461, first published
.

1 NIHR King’s Clinical Research Facility, King's College London, London, United Kingdom
2 European Migraine and Headache Alliance, Brussels, Belgium
3 Sanofi, Gentilly, France
